SURF BIO
Surf Bio is a preclinical biopharmaceutical company leveraging a breakthrough next-generation surfactant to develop enhanced therapeutic solutions for diabetes, oncology, infectious diseases, gene therapy, and other therapeutic areas.
SURF BIO
Social Links:
Industry:
Biotechnology Oncology Pharmaceutical Therapeutics
Founded:
2021-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.surf.bio
Total Employee:
1+
Status:
Active
Total Funding:
17.6 M USD
Technology used in webpage:
Amazon
Similar Organizations
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Laurantis Pharma
Laurantis Pharma develops therapeutics for medical niche indications in the dermatology, ophthalmology, and oncology sectors.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Surf Bio
Perceptive Advisors
Perceptive Advisors investment in Seed Round - Surf Bio
Breakout Ventures
Breakout Ventures investment in Seed Round - Surf Bio
Official Site Inspections
http://www.surf.bio
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Surf Bio"
Surf Bio
Mar 14, 2025 Launched in 2021 by the founders of Bigfoot Biomedical and Mode AGC, Surf Bio is a preclinical biopharmaceutical company that is transforming how antibodies and biologics are delivered to patients. Surf โฆSee details»
Surf Bio 2025 Company Profile: Valuation, Funding & Investors
Surf Bio General Information Description. Developer of a novel biotechnology platform designed to improve drug effectiveness. The company's platform is used to develop improved โฆSee details»
Surf Bio - Crunchbase Company Profile & Funding
Organization. Surf Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Surf Bio is a preclinical โฆSee details»
SURF BIO, INC. Company Profile | Palo Alto, CA | Competitors ...
Find company research, competitor information, contact details & financial data for SURF BIO, INC. of Palo Alto, CA. Get the latest business insights from Dun & Bradstreet.See details»
Surf Bio - VentureRadar
Surf Bio was founded to commercialize a breakthrough drug stabilization technology developed in the Appel Lab at Stanford University. Surf Bio is a preclinical biopharmaceutical company โฆSee details»
Surf Bio - BIO International Convention 2025
Surf Bioโs SnapShotโข technology enables simple, at-home subcutaneous administration of high-dose mAbs and biologics using standard autoinjectors. Our proprietary polymer platform โฆSee details»
Surf Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Surf Bio was launched by the founders of Bigfoot Biomedical and Mode AGC to commercialize a breakthrough drug stabilization technology developed in the Appel lab at Stanford University. โฆSee details»
Surf Bio | CipherBio
Explore Surf Bio's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Surf Bio - Products, Competitors, Financials, Employees, โฆ
Surf Bio Appoints Industry Veteran Doug Hecker as Head of Technical Operations. Mar 14, 2025. News provided by Share this article Brings 30+ Years of CMC Expertise to Advance High โฆSee details»
Surf Bio - Biotech Careers
Surf Bio is a preclinical biopharmaceutical company leveraging a breakthrough next-generation surfactant to develop enhanced therapeutic solutions for diabetes, oncology, infectious โฆSee details»
Surf Bio Announces $16 Million Series Seed Financing
Apr 16, 2022 Surf Bio was launched by the founders of Bigfoot Biomedical and Mode AGC to commercialize a breakthrough drug stabilization technology developed in the Appel Lab. โฆSee details»
Founder Spotlight #41: Bryan Mazlish @ Surf Bio - Medium
Jun 6, 2022 Surf Bio is a preclinical biopharmaceutical company leveraging a breakthrough next-generation surfactant to develop enhanced therapeutic solutions for diabetes, oncology, โฆSee details»
Surf Bio - Funding, Financials, Valuation & Investors - Crunchbase
Apr 12, 2022 Surf Bio develops therapeutic solutions for diabetes, oncology, infectious diseases, and gene therapy. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How โฆSee details»
SURF BIO โ Funding, Valuation, Investors, News
Surf Bio Raises $16M in Seed Financing: Surf Bio, a Palo Alto, CA-based biopharmaceutical company, raised $16M in Seed funding. The round was led by Breakout Ventures and โฆSee details»
Surf Bio - VentureRadar
Surf Bio was founded to commercialize a breakthrough drug stabilization technology developed in the Appel Lab at Stanford University. Surf Bio is a preclinical biopharmaceutical company โฆSee details»
Surf Bio - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Surf Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of Board โฆSee details»
Jennifer Schneider - Founder, President & Board Member @ Surf โฆ
Jennifer Schneider is the Founder and President of Surf Bio. She previously worked at the California Institute for Regenerative Medicine as a Clinical Advisory Panel. Jennifer Schneider โฆSee details»
SURFBIO โ Innovation Hub for Surface and Colloid Biology Research
From the Joลพef Stefan Institute, Sloveniaโs leading scientific research institute, together with five top research & innovation partners across Europe, we are creating an innovation hub to study โฆSee details»
Surf Bio Announces $1.6 Million Non-Dilutive Grant - BioSpace
Apr 30, 2024 PALO ALTO, Calif.--(BUSINESS WIRE)-- Surf Bio, Inc., a biopharmaceutical company commercializing a novel drug stabilization platform, has received a $1.6 million grant โฆSee details»
Whatโs SURFBIO? โ SURFBIO
In December 2020, SURFBIO, a project to boost an Innovation Hub for Surface and Colloid Biology Research, kicked off in an online meeting.SURFBIO, a project funded by the โฆSee details»